LetterCorrespondence
Mycophenolate Mofetil in Refractory Cutaneous Lupus Erythematosus: No Definitive Evidence
CLAUDE BACHMEYER, SIMON GALMICHE, ANTOINE FAYAND, ALEXANDRE DEGACHI and SOPHIE GEORGIN-LAVIALLE
The Journal of Rheumatology September 2016, 43 (9) 1766; DOI: https://doi.org/10.3899/jrheum.160437
CLAUDE BACHMEYER
Service de Médecine Interne, Hôpital Tenon (APHP);
MDSIMON GALMICHE
Service de Médecine Interne, Hôpital Tenon (APHP);
MDANTOINE FAYAND
Service de Médecine Interne, Hôpital Tenon (APHP);
MDALEXANDRE DEGACHI
Service de Médecine Interne, Hôpital Tenon (APHP);
MDSOPHIE GEORGIN-LAVIALLE
Service de Médecine Interne, Hôpital Tenon (APHP), Paris,
France.
MD, PhDREFERENCES
- 1.↵
- Tselios K,
- Gladman DD,
- Su J,
- Urowitz MB
- 2.↵
- Kuhn A,
- Landmann A
- 3.↵
- Gladman DD,
- Ibañez D,
- Urowitz MB
- 4.↵
- 5.↵
- 6.↵
- Mok CC,
- Penn HJ,
- Chan KL,
- Tse SM,
- Langman LJ,
- Jannetto PJ
- 7.↵
In this issue
The Journal of Rheumatology
Vol. 43, Issue 9
1 Sep 2016
Mycophenolate Mofetil in Refractory Cutaneous Lupus Erythematosus: No Definitive Evidence
CLAUDE BACHMEYER, SIMON GALMICHE, ANTOINE FAYAND, ALEXANDRE DEGACHI, SOPHIE GEORGIN-LAVIALLE
The Journal of Rheumatology Sep 2016, 43 (9) 1766; DOI: 10.3899/jrheum.160437